HilleVax (HLVX) Competitors $2.09 0.00 (0.00%) As of 09/17/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HLVX vs. SLDB, ATXS, KMDA, GLUE, ZVRA, FULC, YMAB, AURA, INBX, and ADCTShould you be buying HilleVax stock or one of its competitors? The main competitors of HilleVax include Solid Biosciences (SLDB), Astria Therapeutics (ATXS), Kamada (KMDA), Monte Rosa Therapeutics (GLUE), Zevra Therapeutics (ZVRA), Fulcrum Therapeutics (FULC), Y-mAbs Therapeutics (YMAB), Aura Biosciences (AURA), Inhibrx Biosciences (INBX), and ADC Therapeutics (ADCT). These companies are all part of the "pharmaceutical products" industry. HilleVax vs. Its Competitors Solid Biosciences Astria Therapeutics Kamada Monte Rosa Therapeutics Zevra Therapeutics Fulcrum Therapeutics Y-mAbs Therapeutics Aura Biosciences Inhibrx Biosciences ADC Therapeutics HilleVax (NASDAQ:HLVX) and Solid Biosciences (NASDAQ:SLDB) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation. Do analysts rate HLVX or SLDB? HilleVax presently has a consensus target price of $2.00, indicating a potential downside of 4.31%. Solid Biosciences has a consensus target price of $15.00, indicating a potential upside of 172.98%. Given Solid Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Solid Biosciences is more favorable than HilleVax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HilleVax 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Solid Biosciences 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Does the media refer more to HLVX or SLDB? In the previous week, Solid Biosciences had 1 more articles in the media than HilleVax. MarketBeat recorded 3 mentions for Solid Biosciences and 2 mentions for HilleVax. Solid Biosciences' average media sentiment score of 0.75 beat HilleVax's score of 0.32 indicating that Solid Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HilleVax 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Solid Biosciences 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in HLVX or SLDB? 86.4% of HilleVax shares are owned by institutional investors. Comparatively, 81.5% of Solid Biosciences shares are owned by institutional investors. 24.9% of HilleVax shares are owned by insiders. Comparatively, 1.9% of Solid Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more volatility and risk, HLVX or SLDB? HilleVax has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Solid Biosciences has a beta of 2.54, suggesting that its share price is 154% more volatile than the S&P 500. Is HLVX or SLDB more profitable? HilleVax's return on equity of -34.29% beat Solid Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets HilleVaxN/A -34.29% -28.50% Solid Biosciences N/A -69.70%-56.74% Which has better valuation and earnings, HLVX or SLDB? Solid Biosciences has higher revenue and earnings than HilleVax. Solid Biosciences is trading at a lower price-to-earnings ratio than HilleVax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHilleVaxN/AN/A-$147.27M-$1.43-1.46Solid Biosciences$8.09M52.89-$124.70M-$2.80-1.96 SummarySolid Biosciences beats HilleVax on 9 of the 15 factors compared between the two stocks. Get HilleVax News Delivered to You Automatically Sign up to receive the latest news and ratings for HLVX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HLVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLVX vs. The Competition Export to ExcelMetricHilleVaxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$104.79M$3.13B$5.75B$10.36BDividend YieldN/A2.37%5.86%4.62%P/E Ratio-1.4621.2176.6126.83Price / SalesN/A255.25452.6189.74Price / CashN/A45.4837.2260.63Price / Book0.679.6513.926.37Net Income-$147.27M-$53.02M$3.29B$271.28M7 Day PerformanceN/A0.49%0.26%1.87%1 Month Performance1.46%4.93%4.92%7.43%1 Year Performance15.47%11.01%85.89%30.62% HilleVax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLVXHilleVax1.5139 of 5 stars$2.09flat$2.00-4.3%+16.0%$104.79MN/A-1.4620News CoverageShort Interest ↑SLDBSolid Biosciences2.9053 of 5 stars$5.42-1.4%$15.00+177.0%-25.9%$421.67M$8.09M-1.93100Gap UpATXSAstria Therapeutics3.0969 of 5 stars$7.36-0.1%$29.00+294.0%-35.7%$415.36MN/A-3.6630News CoverageAnalyst ForecastGap UpKMDAKamada4.4567 of 5 stars$7.06+3.3%$13.00+84.2%+30.4%$405.79M$160.95M20.75360News CoveragePositive NewsShort Interest ↓GLUEMonte Rosa Therapeutics2.6891 of 5 stars$6.55-5.5%$15.33+134.2%+7.4%$405.76M$75.62M18.2590Trending NewsAnalyst RevisionHigh Trading VolumeZVRAZevra Therapeutics2.9997 of 5 stars$7.21-0.3%$23.71+228.9%-2.7%$404.45M$62.02M-34.3120News CoverageFULCFulcrum Therapeutics2.6112 of 5 stars$7.29+3.2%$9.60+31.6%+109.7%$394.87MN/A-5.98100News CoveragePositive NewsShort Interest ↓YMABY-mAbs Therapeutics1.9951 of 5 stars$8.60+0.1%$9.62+11.9%N/A$390.77M$85.39M-17.20150AURAAura Biosciences2.0875 of 5 stars$6.29+5.3%$22.00+249.9%-36.3%$389.80MN/A-3.2050Positive NewsINBXInhibrx Biosciences1.2991 of 5 stars$26.60-2.2%N/A+54.1%$384.79M$1.40M-2.51166Positive NewsADCTADC Therapeutics3.1871 of 5 stars$3.32+3.6%$7.75+133.8%+4.3%$375.18M$77.25M-2.12310Positive News Related Companies and Tools Related Companies SLDB Competitors ATXS Competitors KMDA Competitors GLUE Competitors ZVRA Competitors FULC Competitors YMAB Competitors AURA Competitors INBX Competitors ADCT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HLVX) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HilleVax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HilleVax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HLVX Stock Alerts